Cotiviti nears $3 billion deal to acquire Edifecs, rejecting higher bid from UnitedHealth. Antitrust concerns cited.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Q4 2024 Earnings Call Transcript February 4, 2025 KKR & Co. Inc. beats earnings expectations. Reported EPS is $1.32, ...

Evercore ISI analyst Glenn Schorr maintained a Buy rating on KKR & Co (KKR – Research Report) yesterday and set a price target of $165.00.

CENTRAL TRUST Co increased its position in KKR & Co. Inc. (NYSE:KKR – Free Report) by 27.0% in the 4th quarter, according to ...

XOi, a leading provider of jobsite-focused technology solutions for the field service ecosystem, today announced the ...

Barclays analyst Benjamin Budish lowered the firm’s price target on KKR (KKR) to $181 from $185 and keeps an Overweight rating on the shares ...

KKR-backed healthcare data company Cotiviti is close to securing a deal to buy smaller rival Edifecs for just over $3bn, after it opted against accepting a higher bid from UnitedHealth Group out of ...

Chakravarthy made a comeback to the Indian unit in the home series against Bangladesh in October 2024 and is the leading ...

Tech groups and clean power builders are partnering to co-locate data centers and power generation to reduce permitting and ...

It was the unexpected World War One treatment centre created by a woman determined to do her bit. Florence Rudge's home ended ...

Japanese trading house Itochu is considering investing in the owner of 7-Eleven, emerging as the latest player in an ...